Orthofix Medical (OFIX) Cash from Investing Activities Growth (1y) (2011 - 2026)
Orthofix Medical (OFIX) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 0.00% |
| 10 | Orthofix Medical | 409.47 Mn | 305.06 Mn | 149.71 Mn | -78.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -78.20% |
| Mar 31, 2026 | -56.10% |
| Dec 31, 2025 | -857.80% |
| Sep 30, 2025 | -68.78% |
| Jun 30, 2025 | 26.96% |
| Mar 31, 2025 | 38.01% |
| Dec 31, 2024 | 92.46% |
| Sep 30, 2024 | 73.76% |
| Jun 30, 2024 | 24.21% |
| Mar 31, 2024 | -163.61% |
| Dec 31, 2023 | -155.14% |
| Sep 30, 2023 | -308.24% |
| Jun 30, 2023 | -71.06% |
| Mar 31, 2023 | 401.46% |
| Dec 31, 2022 | 34.31% |
| Sep 30, 2022 | -29.11% |
| Jun 30, 2022 | -49.55% |
| Mar 31, 2022 | -18.53% |
| Dec 31, 2021 | 4.35% |
| Sep 30, 2021 | 70.51% |